Skip to main content
Premium Trial:

Request an Annual Quote

Policy Changes Needed to Prevent Disparities in Genetically Based Medicine

NEW YORK (GenomeWeb) – Despite the promise of genetically based diagnoses and treatments, ensuring that disadvantaged groups can benefit from such medical advances will require a number of changes in healthcare and research policies, according to a new report published this week.

"Unprecedented advances in genetically based diagnoses and treatments provide opportunities for personalized medicine," Tufts University researcher Jose Ordovas and his colleagues wrote in Health Affairs. "However, disadvantaged groups may lack access to these advances, and treatments based on research on non-Hispanic whites might not be generalizable to members of minority groups. Unless genetic technologies become universally accessible, existing disparities could be widened."

In the paper, the team — which included scientists from the University of Washington, the University of Illinois at Chicago, Ohio State University, Johns Hopkins University, the University of North Carolina at Chapel Hill, the University of Massachusetts, and the Black Hills Center for American Indian Health — focused on breast cancer and chronic kidney disease to highlight the existence of racial and ethnic disparities in healthcare.

To address the problem, the researchers recommended expanding genetic research to include more non-white participants, as well as efforts to promote participation in community-based research to help improve genetic literacy. They also called for increased funding to support efforts studying the interplay between genetics and the environment, and enhancing access to genetic technologies for minority populations in ways that avoid stigmatization.

"We need to collect more data from groups for whom we currently have insufficient information so that we can improve care for all individuals," Ordovas said in a statement. "Increasing diversity in research and testing will help maximize the possibilities of precision medicine."

The Scan

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.

Lupus Heterogeneity Highlighted With Single-Cell Transcriptomes

Using single-cell RNA sequencing, researchers in Nature Communications tracked down immune and non-immune cell differences between discoid lupus erythematosus and systemic lupus erythematosus.

Rare Disease Clues Gleaned From Mobile Element Insertions in Exome Sequences

With an approach called MELT, researchers in the European Journal of Human Genetics uncovered mobile element insertions in exomes from 3,232 individuals with or without developmental or neurological abnormalities.

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.